← Practice

Topic primers

A quick on-ramp for each area: the handful of facts that anchor it. Read one, then go practice. These are a launchpad, not a lecture.

PRIMER · Patient Safety & Quality Assurance

Patient safety essentials

  • High-alert means severe harm if used in error (insulin, heparin, opioids, concentrated electrolytes).
  • Tall-man lettering distinguishes look-alikes (DOPamine vs DOBUTamine).
  • Do Not Use: write 'unit' not 'U', no trailing zero (5 mg), always a leading zero (0.5 mg).
  • MedWatch Form 3500 is voluntary; Form 3500A is mandatory.
  • A near-miss is caught before harm; a sentinel event reaches the patient with serious harm.
Practice Patient Safety & Quality Assurance
PRIMER · Patient Safety & Quality Assurance

Sterile compounding and USP standards

  • USP <795> covers nonsterile, <797> sterile, and <800> hazardous drug compounding.
  • Garb dirtiest-to-cleanest; sterile gloves go on last, inside the clean area.
  • A laminar airflow hood provides ISO Class 5 air; a HEPA filter removes at least 99.97% of 0.3-micron particles.
  • Disinfect the direct compounding area with sterile 70% IPA at least every 30 minutes during compounding.
  • A beyond-use date (BUD) applies to the compounded preparation, not the manufacturer's expiration date.
Practice Patient Safety & Quality Assurance
PRIMER · Patient Safety & Quality Assurance

Medication safety at a glance

  • High-alert drugs (insulin, heparin, opioids, concentrated electrolytes) cause severe harm if misused; double-check them.
  • Look-alike/sound-alike names use tall-man lettering to tell them apart (hydrALAZINE vs hydrOXYzine).
  • Avoid error-prone abbreviations: U (write 'unit'), IU, QD/QOD, and MS; spell them out.
  • Use a leading zero (0.5 mg) and no trailing zero (5 mg) to prevent 10-fold dosing errors.
  • The rights of medication use: right patient, drug, dose, route, and time (plus documentation).
Practice Patient Safety & Quality Assurance

Showing Patient Safety & Quality Assurance only. See every primer.